Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines
| Autor: | Bodnar, L. *, Stec, R., Cierniak, S., Synowiec, A., Wcisło, G., Jesiotr, M., Koktysz, R., Kozłowski, W., Szczylik, C. |
|---|---|
| Zdroj: | In Annals of Oncology July 2015 26(7):1385-1389 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|